J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Operating Margin
Jafron Biomedical Co Ltd

35.6%
Current
40%
Average
4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
35.6%
=
Operating Profit
856.6m
/
Revenue
2.4B

Operating Margin Across Competitors

Country CN
Market Cap 25.7B CNY
Operating Margin
36%
Country US
Market Cap 204.7B USD
Operating Margin
17%
Country US
Market Cap 180.7B USD
Operating Margin
26%
Country US
Market Cap 139.9B USD
Operating Margin
22%
Country US
Market Cap 124.8B USD
Operating Margin
18%
Country IE
Market Cap 114.5B USD
Operating Margin
19%
Country US
Market Cap 67.7B USD
Operating Margin
15%
Country DE
Market Cap 53.6B EUR
Operating Margin
12%
Country CN
Market Cap 338.5B CNY
Operating Margin
37%
Country US
Market Cap 40B USD
Operating Margin
28%
Country US
Market Cap 39.7B USD
Operating Margin
13%

Profitability Report

View the profitability report to see the full profitability analysis for Jafron Biomedical Co Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
35.6%
=
Operating Profit
856.6m
/
Revenue
2.4B
What is the Operating Margin of Jafron Biomedical Co Ltd?

Based on Jafron Biomedical Co Ltd's most recent financial statements, the company has Operating Margin of 35.6%.